Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
CoreWeave, Inc. (CRWV) Chief Development Officer Brannin McBee sold 194,000 shares of Class A Common Stock on June 29, 2026, realizing approximately $18.3 million. The transaction, facilitated by a Rule 10b5-1 trading plan established in March 2026, occurred at prices between $90.24 and $98.31 per share. This activity follows a recent 15% decline i…
Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 4,641 shares on July 1, 2026, generating $20,838 in proceeds. The transaction, intended to satisfy tax liabilities from performance-based Restricted Stock Units, occurred at an average price of $4.49 per share. This activity follows the compan…
C3.ai Inc. (NASDAQ: AI) reported that Chief Financial Officer Hitesh Lath sold $426,388 worth of Class A Common Stock on June 30, 2026, according to a recent SEC filing. The transaction involved 48,619 shares at a weighted-average price of $8.77, with the stock currently trading at $9.43. While the company issued preliminary fiscal 2027 revenue gui…
Sunrun Inc. director Lynn Michelle Jurich recently liquidated a portion of her equity stake, selling 50,000 shares for $680,320. The transaction, executed on July 1, 2026, follows a Rule 10b5-1 trading plan adopted in June 2025. This insider activity unfolds against a backdrop of recent financial outperformance and shifting analyst projections for …
Richard Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a sale of 25,947 shares of common stock on July 1, 2026, totaling $116,242. The transaction, conducted at prices ranging from $4.3402 to $4.7507 with a weighted average of $4.48 per share, was specifically designated to satisfy tax liabilities arisin…
Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker Inc., executed a sale of 36,300 shares of Class A Common Stock on June 29, 2026, resulting in proceeds totaling approximately $1,090,452. The transaction, governed by a Rule 10b5-1 trading plan adopted on September 16, 2025, occurred at per-share prices between $29.99 and $30.35. Th…
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Chief Medical Officer Narinder Pal Bhalla executed a sale of 22,306 shares on July 1, 2026, totaling $98,592. The transaction, conducted at a weighted average price of $4.42 per share, was specifically designated to satisfy tax liabilities associated with the vesting of performance Restricted Stock Units (RSUs…
Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc. (NASDAQ:LXEO), executed a transaction involving the sale of 4,666 shares of common stock on July 1, 2026. The sale, valued at $20,903, was conducted to satisfy tax liabilities associated with the vesting of performance Restricted Stock Units (RSUs). This transaction follows a pr…
Josh D. Paul, the Chief Accounting Officer at Palo Alto Networks Inc (NASDAQ:PANW), has reduced his stake in the cybersecurity firm through recent share transactions. While one portion of the sale was executed under a Rule 10b5-1 plan, another involved shares withheld for tax obligations related to vesting restricted stock units. The executive's ac…
StoneX Group Inc. CEO Philip Andrew Smith executed a significant divestment of company equity, selling 51,540 shares for approximately $6.12 million on June 30, 2026. The transactions followed the exercise of stock options originally granted in December 2021. This financial activity occurs against a backdrop of mixed financial results for the secon…
O-I Glass's 1H 2026 momentum has stalled. A surprise European margin collapse, a material guidance cut and a high debt load weaken the case for further upside from current levels. We recommend a mid-term short trade with defined entry, stop and target while watching catalysts that could flip the thesis.
ClearPoint Neuro Inc. (NASDAQ: CLPT) Chief Executive Officer Joseph Burnett has completed the sale of 20,000 shares of the company's common stock. The transaction, executed on June 29, 2026, was conducted under a pre-arranged trading plan established in June 2025. The sale followed the exercise of stock options originally granted in November 2017. …
Compass Diversified announced its Board of Directors has declared quarterly cash distributions on its Series A, B, and C preferred shares for the second quarter of 2026, payable July 30, 2026. The distributions affirm the company's ongoing commitment to returning value to shareholders through consistent preferred dividend payments.
Michael Olsen, General Counsel and Chief Compliance and Risk Officer at Optimum Communications, Inc., recently finalized several share transactions, including a direct sale and tax-related withholdings. These moves occur against a backdrop of significant corporate restructuring efforts, including a completed tender offer and a credit rating downgra…
Andrew Toy, Chief Executive Officer of Clover Health Investments, Corp., executed a mandatory stock sale on July 1, 2026, to satisfy tax withholding requirements tied to restricted stock unit vesting. The transaction occurred amid recent financial results that showed revenue growth but earnings per share below analyst expectations, alongside a sign…
A proposed class action filed in Manhattan federal court alleges that StubHub failed to provide World Cup tickets purchased on its secondary marketplace, leaving fans with travel expenses and cancelled seats. The complaint accuses the resale platform of false advertising and violations of consumer protection laws; StubHub has attributed the problem…
Columbia Financial, Inc. announced that its stockholders and depositors have approved its plan for a second step conversion from mutual to fully public stock holding company and its acquisition of Northfield Bancorp, Inc. The company raised approximately $1.1 billion in a subscription offering and plans a firm commitment underwritten offering to co…
Precigen Inc. CFO Harry Thomasian Jr. sold 200,000 shares worth approximately $1.1 million between June 29 and July 1, 2026, under a 10b5-1 plan. The sales occurred after a 262% stock surge over the past year, with shares currently trading around $5.25. Despite the executive's divestment, the company reported Q1 2026 earnings that beat analyst expe…
Sushil Patel, a director at Revolution Medicines, Inc. (NASDAQ:RVMD), completed a series of stock transactions on June 29, 2026, resulting in the sale of 5,580 shares for approximately $1.05 million. The activity, conducted under a pre-arranged 10b5-1 trading plan established in March 2026, included the exercise of fully vested stock options at $37…
Rutul R. Shah, Chief Operating Officer at Precigen, Inc. (NASDAQ:PGEN), disposed of shares valued at $251,105 on June 29, 2026, following the exercise of fully vested stock options. The transaction was conducted under a 10b5-1 plan, leaving Shah with a direct holding of 497,751 shares and 157,076 derivative options. This activity occurs against a b…
John Kent Walker, President of Global Affairs and Chief Legal Officer at Alphabet Inc. (NASDAQ:GOOGL), executed a sale of Class C Capital Stock valued at approximately $3.14 million on June 29, 2026. The transaction was facilitated through a Rule 10b5-1 trading plan established by Walker in his capacity as a trustee for The Arete Trust. This divest…
Precigen Inc. (NASDAQ: PGEN) President and CEO Helen Sabzevari completed the sale of 346,836 shares of company stock on June 29, 2026, generating proceeds of $2,042,864. The transaction followed the exercise of equivalent stock options and occurred near the stock's 52-week high, reflecting a period of significant valuation appreciation. This execut…
Airbnb, Inc. (NASDAQ: ABNB) director and 10% owner Joseph Gebbia sold 294,903 shares of Class A Common Stock on June 29, 2026, realizing approximately $43.8 million from the transaction. The shares were sold at prices ranging from $145.90 to $150.0326 per share. The sale was executed indirectly through the Sycamore Trust under a Rule 10b5-1 trading…
Transocean's recent ~ $1 billion contract win materially strengthens backlog and cash flow visibility. At a market cap near $5.4B, EV/EBITDA ~6.7 and price-to-book ~0.66, the stock looks inexpensive. This trade idea outlines an actionable mid-term long with entry at $4.87, a stop at $3.95 and target at $6.50 (mid term - 45 trading days).
Anthony Bacos, Stitch Fix’s Chief Product and Technology Officer, sold $309,663 worth of the company’s Class A Common Stock on June 29, 2026, under a Rule 10b5-1 trading plan established earlier in the year. The sale of 70,011 shares occurred at prices between $4.35 and $4.51, shortly after the company reported stronger-than-expected fiscal third-q…
